Astellas Pharma Inc (OTC Pink - Limited Information:ALPMF)
| 14.49 Delayed Data As of Sep 21 |  -0.27 / -1.83%Today’s Change | 12.77 Today|||52-Week Range 17.00 | -6.97% Year-to-Date |
Latest ALPMF News | Press Releases
| New Strong Sell Stocks for September18th Sep 18 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 14.76 |
| Today’s open | 14.71 |
| Day’s range | 14.49 - 14.71 |
| Volume | 1,277 |
| Average volume (3 months) | 2,557 |
| Market cap | $27.0B |
Data as of 09/21/2023
Growth & Valuation
| Earnings growth (last year) | -32.96% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -2.85% |
| P/E ratio | -- |
| Price/Sales | 2.30 |
| Price/Book | 2.37 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $11.2B |
| Annual profit (last year) | $728.4M |
| Net profit margin | 6.50% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Tokyo, Tokyo |
Forecasts
Chart unavailable
